Bright Minds Biosciences Secures $175 Million for Expanded Clinical Research—Offering Marks Strategic Shift in Funding Approach
Market Chameleon (Thu, 8-Jan 9:07 AM)
Bright Minds Biosciences Reports 73% Seizure Reduction in Phase 2 BMB-101 Trial—Positive Results Set Stage for Global Studies
Market Chameleon (Tue, 6-Jan 7:51 AM)
